Adi Zuloff-Shani

Adi Zuloff-Shani serves as the Chief Executive Officer of Clearmind Medicine since July 2021, leading a psychedelic pharmaceutical biotech company dedicated to developing novel psychedelic-derived therapeutics for addressing health issues such as alcohol use disorder. Additionally, Adi holds a position on the Scientific Advisory Board of Save Foods Inc. since October 2021 and has been the Chief Technology Officer at Therapix Biosciences Ltd. since February 2016. Previously, Adi served as Vice President of Development and head of new initiatives at Macrocure from October 2008 to March 2016. Adi obtained a Doctor of Philosophy (Ph.D.) in Immunology from Bar-Ilan University between 1995 and 1999.